[1] Hubalewska-Daydejczyk A,Trofimiuk M,Sowa-Staszczak A,et al.Somatostatin receptors expression (SSTR1-SSTR5)in pheochromo-cytomas.Przegl Lek,2008,65(9):405-407.
[2] Shen HC,Wang XW,Liu YG.A tumor growth inhibition of paclitaxel-octreotide conjugates on human non small cell lung cancer experiment with mice.Zhonghua Yi Xue Za Zhi,2008,88(35):2498-2503.
[3] Acunzo J,Thirion S,Roche C,et al.Somatostatin receptor sst2 decreases cell viability and hormonal hypersecretion and reverses octreotide resistance of human pituitary adenomas.Cancer Res,2008,68(24):10163-10170.
[4] Krantic S.Peptides as regulators of the immuse system:emphasis on somatostatin.Peptides,2000,21(12):1941-1946.
[5] Kaszper E,Hanzély Z,Szende B,et al.Examination of somatostatin receptor expression in recurrent childhood medulloblastomas.Magy Onkol,2008,52(4):351-355.
[6] Virgolini I,Traub T,Novotny C,et aL Experience with indium-111 and yttrium-90-labeled somatostatin analogs.Curr Pharm Des,2002,8(20):1781-1807.
[7] Elgeti F,Amthauer H,Denecke T,et al.Incidental detection of breast cancer by 68Ga-DOTATOC-PET/CT in women suffering from neuroendocrine tumours.Nuklearmedizin,2008,47(6):261-265.
[8] Kuan CT,Wikstrand CJ,Me Lendon RE,et al.Detection of amino-terminal extracellular domain of somatostatin receptor 2 by specific monoclonal antibodies and quantification of receptor density in medulloblastoma.Hybridoma,2009,28(6):389-403.
[9] Pisarek H,Stepień T,Kubiak R,et al.Somatostatin receptors inhuman adrenal gland tumors-immunohistochemical study.Folia Histochem Cytobiol,2008,46(3):345-351.
[10] Thomson VS,Narayanan K,Singh JC.Contrast induced nephropathy in urology.Indian J Urol,2009,25(4):437-445.
[11] Wild D,Schmitt JS,Cinj M,et al.DOTA-NOC,a high-affinity ligand of somatostatin receptor subtypes 2,3 and 5 for labelling with various radiometals.Eur J Nucl Med Mol Imaging,2003,30(10):1338-1347.
[12] Shah T,Kulakiene I,Quigley AM,et al.The role of 99mTc-depreotide in the management of neuroendocrine tumours.Nucl Medi Commun,2008,29(5):436-440.
[13] Van Den Bossche B,Van Belle S,De Winter F,et al.Early prediction of endocrine therapy effect in advanced breast cancer patients using 99mTc-depreotide scintigraphy.J Nucl Med,2006,47(1):6-13.
[14] Blum J,Nandmaker H,Lister-James J,et al.A multicenter trial with a somatostatin analog 99Tcm depreotide in the evaluation of solitary pulmonary nodules.Chest,2000,117(5):1232-1237.
[15] 王峰,王自正,姚薇萱,等.99Tcm-sandostatin生长抑素受体显像用于诊断肺癌.中华核医学杂志,2004,24(2):104-106.
[16] Schottelius M,Wester HJ,Heubi JC,et al.Improvement of pharmacokinetics of radioiodinated Tyr(3)-octreotide by conjugation with carbohydrates.Bioconjug Chem,2002,13(5):1021-1030.
[17] Lebtahi R,Le Cloirec J,Houzard C,et al.Detection of neuroendocrine tumors:99mTC-P829 scintigraphy compared with 111In-pentetreotide scintigraphy.J Nucl Med,2002,43(7):889-895.
[18] Wester HJ,Schottelius M,Scheidhauer K,et al.PET imaging of somatostatin receptors:design,synthesis and preclinical evaluation of a novel 18F-labelled,carbohydrated analogue of octreotide.Eur J Nucl Med Mol Imaging,2003,30(1):117-122.
[19] Wester HJ,Schottelius M,Scheidhauer K,et al. Comparison of radioiodinated TOC,TOCA and Mtr-TOCA:the effect of carbohydration on the pharmacokinetics.Eur J Nucl Med Mol Imaging,2002,29(1):28-38.
[20] Virgolini I,Britton K,Buscombe J,et al.111In-and 99Y-DOTA-lanreotide:results and implications of the MAURITIUS trial.Semin Nucl Med,2002,32(2):148-155.
[21] Wild D,Häcke HR,Waser B,et al.68Ga-DOTANOC:a first compound for PET imaging with high affinity for somatostatin receptor subtypes 2 and 5.Eur J Nucl Med Mol Imaging,2005,32(6):724.
[22] Maggio R,Aloisi G,Silvano E,et al.Heterodimerization of dopamine receptors:new insights into functional and therapeutic significance.Parkinsonism Relat Disord,2009,15(4):S2-S7.
[23] Lee LT,Schally AV,Liebow C,et al.Dephosphorylation of cancer protein by tyrosine phosphatases in response to analogs of luteinizing hormone-releasing hormone and somatostatin.Anticancer Res,2008,28(5A):2599-2605.
[24] Barresi V,Alafaci C,Salpietro F,et al.Sstr2Aimmunohisto-chemical expression in human meningiomas:is there a correlation with the histological grade,proliferation or microvessel density?.Oncol Rep,2008,20(3):485-492.